Related Experiment Videos
A rapid empirical method for measuring membrane bilayer entry equilibration of molecules
1Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA. Donald.Melchior@umassmed.edu
Journal of Pharmaceutical Sciences
|April 12, 2002
Summary
This study introduces Fluorosomes, fluorescently labeled liposomes, to measure how quickly drugs penetrate cell membranes. This new method aids in high-throughput drug screening by assessing drug entry into lipid bilayers.
Area of Science:
- Biochemistry
- Pharmacology
- Materials Science
Background:
- Drug efficacy is often limited by interactions with cell membranes.
- A drug's ability to cross lipid barriers, like cell membranes and the blood-brain barrier, is critical for its effectiveness.
- Understanding drug penetration into lipid bilayers is essential for drug development.
Purpose of the Study:
- To demonstrate the utility of fluorescently labeled liposomes (Fluorosomes) for measuring small molecule penetration into lipid bilayers.
- To establish a method for quantifying drug entry into membrane lipid bilayers.
- To provide a tool for assessing drug-membrane interactions relevant to therapeutic potency.
Main Methods:
- Development and application of fluorescently labeled liposomes (Fluorosomes).
- Measurement of the rate of penetration of small molecules into membrane lipid bilayers.
- Determination of half-times for bilayer entry equilibration of various compounds at micromolar concentrations.
Main Results:
- Fluorosomes effectively measure the rate of small molecule penetration into lipid bilayers.
- The technique allows for the determination of drug entry half-times ranging from milliseconds to hours.
- The method is applicable to a wide variety of compound types at micromolar drug concentrations.
Conclusions:
- Fluorescently labeled liposomes (Fluorosomes) provide a valuable in vitro method for measuring drug penetration into lipid bilayers.
- This technique facilitates the assessment of non-protein facilitated drug entry into the lipid phase of membranes.
- The developed method is suitable for high-throughput screening of drugs, aiding in the identification of more effective therapeutics.